FDA panel favors Glaxo, Ligand blood drug AP via Yahoo! News Fri, 30 May 2008 2:06 PM PDT Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline PLC and Ligand Pharmaceuticals Inc. is effective for short-term use, despite reservations by FDA scientists. | FDA: Switch to HFA-propelled inhaler UPI Fri, 30 May 2008 3:09 PM PDT WASHINGTON, May 30 (UPI) -- The U.S. Food and Drug Administration issued a public health advisory that chlorofluorocarbon, or CFC-propelled inhalers will not be available next year. | Letters for Saturday, May 31, 2008 The Record Fri, 30 May 2008 10:35 PM PDT The Food and Drug Administration may be looking in the wrong place. The head of the FDA says, "We still have a percentage of patients who are having unsatisfactory results." Why not be candid and say, "We still have a percentage of doctors who are giving unsatisfactory service"? | NATIONAL BRIEFS Fort Worth Star-Telegram Sat, 31 May 2008 2:49 AM PDT FDA: Old inhalers must go WASHINGTON -- Old-fashioned asthma inhalers that contain environment-harming chemicals will no longer be sold after year's end, and the Food and Drug Administration is urging patients to ask their doctor about switching now. Patients use inhalers to dispense airway-relaxing albuterol during asthma attacks. Chemicals called CFCs, for chlorofluorocarbons, were once ... | Wyeth gets Fast Track designation for pneumococcal conjugate vaccine PharmaBiz Sat, 31 May 2008 1:42 AM PDT Wyeth Pharmaceuticals, a division of Wyeth announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to the company's investigational 13-valent pneumococcal conjugate vaccine for infants and toddlers. | FDA: Use ozone-friendly inhalers Albany Times Union Sat, 31 May 2008 0:16 AM PDT WASHINGTON -- Old-fashioned asthma inhalers that contain environment-harming chemicals will no longer be sold at year's end -- and the Food and Drug Administration is urging patients not to wait until the last minute to switch to newer alternatives.Chemicals called chlorofluorocarbons, or CFCs, once were widely used to propel the drug into the lungs. But CFC-containing consumer products are ... | CFC-propelled inhalers no longer available as of Dec. 31 2008 News-Medical-Net Fri, 30 May 2008 12:16 PM PDT The U.S. Food and Drug Administration today issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane (HFA)-propelled albuterol inhalers because chlorofluorocarbon (CFC)-propelled inhalers will not be available in the United States after Dec. 31, 2008. |
| |
|
No comments:
Post a Comment